BioLattice Ophthalmics, Inc,

Biotechnology company · Philadelphia, Pennsylvania, United States

BioLattice Ophthalmics, Inc, is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $575,000 sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

BioLattice Ophthalmics, Inc at a glance

Typebiotechnology company

HeadquartersPhiladelphia, Pennsylvania, United States

Earliest incorporation on record2023

SEC CIK2125596

What does BioLattice Ophthalmics, Inc do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $575,000 sold (2026).

Frequently asked questions about BioLattice Ophthalmics, Inc

Where is BioLattice Ophthalmics, Inc headquartered?

BioLattice Ophthalmics, Inc, is headquartered in Philadelphia, Pennsylvania, United States.

What does BioLattice Ophthalmics, Inc do?

BioLattice Ophthalmics, Inc, is a biotechnology company.

When was BioLattice Ophthalmics, Inc founded?

The earliest incorporation on record for BioLattice Ophthalmics, Inc, is in 2023, according to public company registers.

Similar companies

Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
Passage BIO, Inc.Philadelphia, Pennsylvania, United States
ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
Enterin, Inc.Philadelphia, Pennsylvania, United States
Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences